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Experimental studies investigating the effects of endocrine disruptors frequently identify potential unconventional
dose-response relationships called non-monotonic dose-response (NMDR) relationships. Standardized approaches
for investigating NMDR relationships in a risk assessment context are missing. The aim of this work was to develop
criteria for assessing the strength of NMDR relationships. A literature search was conducted to identify published
studies that report NMDR relationships with endocrine disruptors. Fifty-one experimental studies that investigated
various effects associated with endocrine disruption elicited by many substances were selected. Scoring criteria
were applied by adaptation of an approach previously used for identification of hormesis-type dose-response
relationships. Out of the 148 NMDR relationships analyzed, 82 were categorized with this method as having a
“moderate” to “high” level of plausibility for various effects. Numerous modes of action described in the literature
can explain such phenomena. NMDR can arise from numerous molecular mechanisms such as opposing effects
induced by multiple receptors differing by their affinity, receptor desensitization, negative feedback with increasing
dose, or dose-dependent metabolism modulation. A stepwise decision tree was developed as a tool to standardize
the analysis of NMDR relationships observed in the literature with the final aim to use these results in a Risk Assessment
purpose. This decision tree was finally applied to studies focused on the effects of bisphenol A.
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Non-monotonic dose-response (NMDR) relationships
are more frequently reported today in experimental
studies than they were 10 years ago [1-3]. The endocrine
disrupting chemicals (EDCs) are regularly associated
with NMDR relationships. Until recently, NMDR rela-
tionships were not considered plausible, and thus they
were not published, reported, or interpreted as relevant
biological phenomena. An increasing number of scien-
tists think that NMDR relationships represent a toxico-
logical reality, but supplementary effort is required to
revisit the Paracelsus principle of “the dose makes the
poison”. Consequently, it is important to avoid rejecting* Correspondence: claire.beausoleil@anses.fr
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unless otherwise stated.studies merely because they do not match the classic
toxicological concept of monotonicity. Before affirming
that such phenomenon exists in a study, a screening
analysis of individual NMDR profile is required to reveal
better understanding of the underlying biological mech-
anism (s) involved and support plausibility of the ob-
served NMDR.
The term “NMDR” describes a dose-response relation-
ship characterized by a curve whose slope changes direc-
tion within the range of tested doses. Non-monotonicity
represents a challenge to fundamental concepts in toxi-
cology and risk assessment. Indeed, environmental risk
assessment approaches used by regulatory agencies
around the world were developed on the basis of a
methodology published by the National Academy of Sci-
ences [4]. For the hazard characterization step, it is gen-
erally accepted that once detectable, a response of an
organism to a toxicant increases proportionally with thel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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effect level (Emax) beyond which increasing toxicant dose
will not increase the response (known as a monotonic
dose-response). To assess the dose-response relationship
of a chemical, several doses are typically tested to define
the no observed adverse effect level (NOAEL) and/or the
lowest observed adverse effect level (LOAEL). The NOAEL
is considered a conservative default threshold below which
a chemical is not expected to induce adverse effects, irre-
spective of the dose [5].
In contrast to this well-accepted hyperbolic or curvi-
linear dose-response relationship, which when plotted as
toxicant effect (ordinate) and the logarithm (log10) of
dose (abscissa) results in a sigmoidal shaped curve, a
NMDR relationship may present as a bell-shaped profile.
This profile, also called inverted-U shape, is character-
ized by responses at intermediate dose (s) and a de-
creased response or no response observed at low- and
high-exposure levels. Also observed in the literature are
U-shaped profiles with the highest responses at low- and
high-exposure levels. In such cases, the standard notion
of threshold, as defined by the NOAEL concept, is not
inclusive of all potentially harmful effects. As clearly
stated by Vandenberg et al. [3], “if a non-monotonic re-
lationship occurs between the doses tested in traditional
toxicology studies (i.e. the NOAEL or NOEL) and the
calculated “safe” or reference dose, this would still have
serious implications for risk assessment”. Thus, the
standard approaches used for setting safe human and
environmental exposure levels by extrapolation from
high dose testing might not be applicable in case of
NMDR profiles. There is a class of toxicants (i.e., EDCs)
for which NMDR relationships, have been experimen-
tally described with relative high frequency compared to
other chemicals [6-11]. The EDCs act through several
modes of action to cause effects on sensitive tissues. As
a result, EDCs can commonly act on many physiological
systems in addition to endocrine tissues. Effects ob-
served in sensitive target tissues can also be caused by
exposure-related changes in mechanisms governing nor-
mal negative feedback regulation of endocrine tissues
and hormone secretion; such effects may also influence
the dose-response relationship depending on exposure
duration. With increasing awareness, more studies are
being specifically designed to address whether the dose-
response relationships for EDCs and other chemicals are
described with an NMDR curve. As a result, NMDR rela-
tionships are being reported with an increasing frequency,
which may have consequences for risk assessment. As re-
ported by Vandenberg et al. [3], regardless of mechanistic
underpinnings of each NMDR, their existence alone chal-
lenged traditional means of risk assessment.
The work described in this manuscript aimed to (1) per-
form a focused literature review, (2) extract a representativeset of observed NMDR relationships for some EDCs and
(3) use that information to develop a methodology to as-
sess whether such a reported dose-response relationship is
sufficiently reliable in order to be used in risk assessments.
The screening analysis method evaluating the likelihood
and the plausibility of the biological mechanisms involved
was applied for each identified NMDR. Then, a stepwise
decision tree was developed as a tool to standardize ana-
lysis for data reliability of observed in vivo NMDR rela-
tionships for risk assessment.
Methods
Screening analysis of the literature
A literature review was conducted by selecting putative
EDCs for which one or more NMDR profiles were ob-
served. Many keywords related to EDCs (i.e., hormones
or exogenous substances for which a general consensus
exists for their endocrine properties) and NMDR rela-
tionships were used to search the PubMed database,
with a data-lock point of January 2012. The keywords
used to screen EDCs were bisphenol* OR phthalate* OR
paraben* OR phenol* OR PCB (polychlorinated biphe-
nyls)* OR diethylstilbestrol OR estrogen* OR estradiol*.
The keywords used to screen NMDR relationships were
hormesis OR hormetic OR non-monotonic OR inverted-
U OR U-shape* OR J-shape* OR bell-shape* OR biphasic.
All published articles outlining an NMDR relationship
with a tested compound were selected.
To determine whether the existence of an NMDR rela-
tionship was supported by the available data, a qualitative
methodology was applied by considering the statistical
strength and the biological plausibility of each reported
NMDR profile. To assess the statistical strength of NMDR
profile, an appropriate statistical analysis based on individ-
ual results demonstrating the non-monotonic nature of
each dose-response relationship is essential. There were
cases in which a proper statistical analysis was not per-
formed by the authors and individual data were poorly
reported. Therefore, in these cases, it was difficult to con-
firm a posteriori that the observed relationships were sta-
tistically significant for a non-monotonic behavior. For
those cases, specific scoring criteria were applied to assess
the strength of the NMDR relationships. This scoring cri-
teria was derived from the identification criteria proposed
by Calabrese and Baldwin [12] for hormesis (a specific
type of NMDR profile).
The biological plausibility of NMDR relationships
reported as significant, or scored to have sufficient
strength, were evaluated by considering whether mech-
anistic explanations were proposed or demonstrated for
the observed dose-response relationship. If the pro-
posed hypotheses were supported by experimental evi-
dence, then the biological plausibility was considered as
reinforced.
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A stepwise decision tree was developed (Figure 1) to as-
sess whether observed NMDR profiles for EDCs could
be used in the context of risk assessment. Using this ap-
proach, data is first qualified using the Klimisch score as
an ancillary approach to assess quality of the study and
the experimental data [13]. If the quality is identified as
Category 3 or 4, then the study will be characterized as
an inconclusive NMDR relationship.
If the quality of the study is Category 1 or 2, then we
will proceed to the second step and consider the number
of tested doses analyzed in the study. If less than or
equal to three (inclusive of the negative control), the
number of doses will be judged to be insufficient toYes
No
Low or moderate 
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NMDR relationship explained by known molecular 
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Figure 1 Decision tree describing the methodology for evaluating theestablish a dose-response relationship and the study is
characterized as an inconclusive NMDR relationship.
For studies with more than three doses, the third step
depends on the availability (or not) of adequate experi-
mental data to continue the plausibility assessment of a
NMDR. To assess the strength of NMDR profile, an
appropriate statistical analysis investigating the non-
monotonic nature of each dose-response relationship is
most appropriate because it is based on individual re-
sults. So when an adequate amount of data is available, a
statistical assessment is performed. An NMDR is consid-
ered plausible if the results are significant (p < 0.05).
However, individual data are often too poorly reported
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Table 2 Summary of total score for plausibility of an
NMDR relationship







aThese scores were extracted from Calabrese and Blain (2011) [14].
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procedure is applied in a fourth step to assess the strength
of the NMDR relationships. This scoring procedure is de-
rived from the criteria proposed by Calabrese and Baldwin
[12] for hormesis (a specific type of NMDR profile).
Briefly, the procedure developed by Calabrese and Baldwin
is a numeric scoring assignment value including the num-
ber of tested dose levels, the magnitude of the response as-
sociated with each dose compared to the basal level, the
significance of the response at each dose, and the presence
of other studies confirming these data (Table 1). These cri-
teria were used because we considered these parameters
important and sufficient to define the non-monotonic na-
ture of a dose-response relationship and estimate the
plausibility of a presumed NMDR relationship (Table 2).
The criteria used here are the criteria suggested by
Calabrese and Baldwin adjusted for a use in this appli-
cation. Each score was assessed individually withoutTable 1 Summary of criteria of analysis with assigned
point values used in the evaluation of statistical plausibility
of an NMDR relationship






Experimental determination of ZEP Score B
Yes 1
No 0





Reproducibility of the dose-response relationship Score D
Yes 3
No 0
Magnitude of response (percentage control value) Score Ea
Inverted-U curve U curve
≥100%, ≤125% ≤97%, ≥92% 0,5
>125%, ≤150% <92%, ≥84% 1
>150%, ≤200% <84%, ≥68% 2
>200%, ≤400% <68%, ≥5% 3
>400% <5% 4
aThe point value is multiplied by the number of experimental doses falling
within the corresponding percentage range.
Criteria reported (Table 1) were extracted from Calabrese and Baldwin [12].
The ZEP (zero equivalent point) corresponds to the point where the response
crosses the control value in a hormetic effect.considering whether NMDR relationships were re-
ported or not in the same study. A score of “moderate,”
“moderate–high” or “high” was considered in this work
as indicative of a sufficient strength. The fifth and last step
of the assessment is to determine whether the previously
suspected NMDR relationship is also supported by bio-
logical plausibility. So an additional assessment of the lit-
erature is made to check whether additional information
would support the biological plausibility and then increase
the confidence in the reported NMDR.
The biological plausibility of NMDR relationships re-
ported as significant, or scored to have sufficient strength,
is evaluated by considering whether mechanistic explana-
tions are proposed or demonstrated for the observed
dose-response relationship: (1) the NMDR relationship is
explained or not by high-dose toxicity (e.g., cytotoxicity)
or physico-chemical effects, (2) a known or proposed
mechanism of action that could explain the observed ef-
fect is described, or (3) the existence of in vivo, in vitro, or
in silico experimental data that support a new mechanism
of action. If the proposed hypotheses are supported by ex-
perimental evidence, then the biological plausibility is con-
sidered as reinforced. In this case, the study is considered
as conclusive and qualified useful for risk assessment. If it
is concluded that there is a lack of biological plausibility in
the study or that a mechanistic explanation or a hypoth-
esis is not developed by the authors, the NMDR is scored
as a suspected NMDR, needing either further testing or
mechanistic studies.
Lastly, the developed stepwise decision tree is applied
to a case study focused on BPA in vivo studies showing
NMDR. This case study was selected because the litera-
ture search results identified several in vivo studies
depicting or claiming NMDRs with this compound and
because of the particular interest of the ANSES Working
Group on Endocrine Disrupters and on BPA in particu-
lar, which was under evaluation by this committee.
Results
Literature review of studies describing NMDR relationships
The first step of this analysis was to perform a targeted
literature search, which identified 219 publications in
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lications, 51 experimental studies described one or more
NMDR profiles concerning EDCs and/or natural hor-
mones. Out of these 51 studies, 2 were epidemiological
studies [15,16], 20 were in vitro studies [6,17-35], and 29
were in vivo studies [36-64]. From these 51 studies, 170
dose-effect relationships were claimed by the authors as
NMDR, most of them involving an endocrine disruption
(Table 3). The most often-cited substances were BPA
and 17β-estradiol (E2).
The NMDR profiles were reported for both animal
sexes, for various physiological and behavioral effects,
and for several organs or systems (Table 4). Affected or-
gans and systems included the central nervous system,
hypothalamic-pituitary axis, mammary glands, adrenal
glands, the cardiovascular system, and the male and fe-
male reproductive systems. In 4 studies [26-29], the ef-
fects having the highest occurrence were related to
modulation of prolactin release (12 NMDR relation-
ships) and changes in protein kinase activity (11 NMDR
relationships) in pituitary cells. A modification of the
mammary structure in mice (e.g., numbers and volume
of terminal end buds and density of the mammary epi-
thelium) was reported in 6 publications in which 15Table 3 EDCs and the number of associated NMDR
relationships






















Diethylstilbestrol 12NMDR profiles were identified [39,47,57,58,60,61]. It is
important to note that some NMDR relationships ob-
served with BPA and E2 were related to modes of action
mediated by estrogen receptors and rapid signaling mech-
anisms. These effects include the release of prolactin and
the phosphorylation of protein kinases in pituitary cells,
cardiomyocyte contractility, structural modifications of
mammary terminal end buds, and modification of epi-
didymal weight. Additionally, the epidemiological studies
identified 8 NMDR profiles for metabolic effects associ-
ated with endpoints such as increased body mass index,
insulin resistance, altered triglycerides and high-density
lipoprotein (HDL) levels, and increased risk of soft-tissue
sarcoma.
Quality analysis of NMDR relationships
To evaluate the plausibility of the NMDR profiles ob-
served, a series of criteria was applied based on those
developed by Calabrese and Baldwin [12]. The first cri-
terion was the minimal number of dose tested levels. To
be considered acceptable, in addition to control group to
establish endpoint baseline, a minimum of 3 dose levels
were required.
NMDR relationships were reported in 2 epidemiological
studies [15,16]. Both studies were analyzed to assess the
plausibility of the dose response relationship reported by
the authors. Regarding the study from Tuomisto et al.
[15], the scoring criteria procedure could not be applied
due to data inconsistencies. It was concluded that the
available data were not appropriate for scoring. This con-
clusion was reached because the exposure range was
treated inconsistently and in a manner that resulted in di-
verging conclusions regarding the shapes of reported
dose-response curves. For example, in the case of dioxins,
when the analysis was performed with the World Health
Organization’s toxicity equivalent (WHO-TEQ) expressed
in septiles, the soft tissue sarcoma risk was higher in the
lowest septile than in the other septiles, and the differ-
ences from control was significant in the second and the
sixth septiles. However, when the analysis was performed
with WHO-TEQ expressed in quintiles, the odds ratios
were not significantly different. Moreover, when con-
founders such as sex, age, or education were included in
the analysis, the odds ratios were decreased in a linear
manner. For those reasons, it is unclear whether the ob-
served, decreasing trend of soft tissue sarcoma risk with
increasing exposure to dioxin is non-monotonic. Regard-
ing the study from Lee et al. [16], many significant associ-
ations of persistent organic pollutants (POPs) with
dysmetabolic conditions appeared at a low dose range,
suggesting an inverted U-shaped dose-response relation-
ship. As a result, a quadratic relationship was considered
in specific statistical tests that supported the significance
of several endpoints for some POP exposures. Examples
Table 4 The effects associated with NMDR relationships
Organs and biological
functions involved
Observed effect (with number of associated NMDR relationships)a Substances involved
In vitro studies In vivo studies
Hypothalamus Dopaminergic transmission (2) Aromatase activity in preoptic area (1) E2, octylphenol,
diethylhexylphthalate
(DEHP)
Pituitary gland Cell proliferation (1) GABAergic
transmission (2) Calcium channel activity
(2) Luteinizing hormone (LH) release
(1) Prolactin release (12) Protein kinase
modification (11)
Follicle stimulating hormone (FSH)






Testes Cell proliferation (1)
Spermatid DNA breaks (1)
Weight (2) Testosterone hydroxylase
activity (4)
E2, BPA, ethinyl estradiol












Ovary Progesterone secretion (1) Testosterone
secretion (1) Estradiol secretion (1)
Transcriptional activity (1) PCBs, BPA
Uterus Percentage of epithelial cells ERα + (1)
Progesterone receptor expression (1)
BPA
Breast Modification of mammary epithelium
and terminal end buds (15)
E2, BPA, DES
Brain L-prostaglandin synthase activity (2)










Cell proliferation (1) Intracellular pH (1)
Modification of protein kinase (2)
E2, BPA
Adrenal glands Corticosterone plasma level (1) PCBs
Liver Nuclear receptors expression (5)
Transcriptional factors expression (4)
BPA
Perinatal development Age of puberty (1) Number of newborns
(2) Weight of newborns (4) Anogenital
distance (3) Sex-ratio (2) Newborn
viability (3) Femur length (1) Growth (1)




Behavior Immobility period (1) Spatial memory (2)
Temporal memory (2) Nocturnal activity (1)
Territorial urine-marking (1) Sexual behavior (5)
E2, 17α-estradiol,
BPA, DES
Metabolism Lipids Adiponectin release (2)
Adiponectin expression (1)
Triglycerides levels (1) Lipogenesis gene
expression (10) Cholesterol metabolism
gene expression (4)
BPA
Glucose Glucose metabolism gene expression (2)
Insulin levels (1)
BPA
Immunity Mast cells degranulation (4) Rate of degranulated eosinophils and
last cells (1) Macrophagic activity (1)
Severity of allergic skin lesions (1)
E2, organochlorines,
alkylphenols, DEHP
Cancer Tumor multiplicity (1) Tumor volume (1)
Latency period for first tumor (1)
Percentage of lung metastases (1)
BPA
aNumbers in parentheses represent the number of NMDR relationships associated with each corresponding effect.
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Table 6 Mechanistic hypotheses reported in corresponding
studies
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esterol level include p,p’-dichlorodiphenyldichloroethylene
(DDE), polychlorobiphenyls (PCB-170, and PCB-206). Ex-
amples of these exposures for triglyceride levels include p,
p’-DDE, oxychlordane, and trans-nanochlor. Based on the
statistically significant results of the reported NMDR rela-
tionship, it was then unnecessary to use the criteria ana-
lysis derived from Calabrese and Baldwin [12]. Decision
not to further consider this study was made mainly be-
cause of the categorical classification of exposure which
results in the ability to only associate a dose range, rather
than a specific exposure, to an observed outcome. There-
fore a decision was made not to include a detailed and
specific assessment of these two epidemiological studies.
Of the 162 NMDR profiles reported in the selected
in vitro and in vivo studies, 14 were rejected for at least
one reason (number of tested doses less than 4, absence
of control, no individual numerical values, or absence of
statistical tests assessing the significance of the differ-
ences between measured values). In some studies (e.g.
[39,46,49,60]), the authors documented specific statis-
tical analyzes that were considered to be valid or to sat-
isfy criteria for non-monotonicity. The dose-response
relationships were therefore considered having a high
plausibility for non-monotonicity. In the other studies
reviewed, no specific statistical analysis was used to verify
the non-monotonic nature of the dose-response relation-
ships. The remaining 148 NMDR relationships were then
analyzed using the adapted scoring criteria (Table 5). Out
of those 148 reported NMDR relationships, 82 were con-
cluded to have moderate, moderate–high, or high plausi-
bility of being non-monotonic. There were no NMDR
profiles classified in the “no–low” plausibility category,
mainly because dose-effect relationships identified from
studies with only three tested doses, including the control,
were a priori rejected and unscored.
Biological plausibility analysis
In 20 out of the 51 experimental studies, no mechanistic
hypothesis for the observed NMDR relationships was
proposed by the authors. In the 31 remaining studies, the
authors suggested multiple physiological mechanisms to
explain the observed effects. Proposed mechanisms orTable 5 The statistical plausibility of NMDR relationships
Plausibility of NMDR relationships n (in vitro) n (in vivo) n (total)
No–low 0 0 0
Low 9 29 38
Low–moderate 9 20 29
Moderate 9 17 26
Moderate–high 6 10 16
High 20 20 40
Note: n = the number of NMDR relationships.mode of action included actions at several molecular tar-
gets (e.g., receptors, ion channels and signaling proteins)
with differing affinities for the substance, the induc-
tion of antagonistic effects, negative feedback regula-
tion to reduce responses, or receptor desensitization.
Additional factors proposed as possibly responsible for
NMDR relationships included dose-dependent metabolism
modulation, high dose toxicity, and/or a dose-dependent
protein ionization to generate chaotropic modulation of
activity (Table 6).
The most frequent hypothesis proposed to explain
NMDR profiles was related to induction of opposing ef-
fects (e.g., agonist versus antagonist) across the range of
the tested doses. These effects could be initiated by sev-
eral molecular targets (predominantly receptors) that
could be differentially activated by the same substance at
different concentration levels and would be dependent
on the affinity of the targets for the substance (Figure 2).
This differential activation could be exemplified by sev-
eral studies conducted on substances such as BPA, E2,
phytoestrogens, diethylstilbestrol [DES] with known dif-
ferences in affinity for ERα and ERβ, which can induce
opposing effects in various cells, tissues, or organs at spe-
cific concentration levels [6,18,27,43,60,61]. Moreover, two
studies described an altered balance between proliferative
and proapoptotic effects potentially arising from differen-
tial receptor activation at different doses [16,45].
Another commonly proposed hypothesis to explain an
observed NMDR was negative feedback regulation
mechanisms related to physiological endocrine control
of hormone actions [65,66]. However, in most of the
studies identified, the authors considered that other un-
known factors, in addition to negative feedback regula-
tion, were necessary to result in the observed dose-
response relationships.
Receptor desensitization could also explain NMDR rela-
tionships (Figure 3). This phenomenon generally results
from a mechanism involving protein phosphorylation,
endocytosis, or repression of target receptor expression,
leading to decreased receptor activity and insensitivity ofMechanistic hypotheses References
Existence of several molecular targets




Negative feedback phenomenon [6,25,31,36,47,50,57,58,60,61,63]





Dose-dependent protein ionization [35]
Figure 2 Mechanism of the NMDR relationship phenomenon induced by the “plurality of molecular targets”. At low concentrations, EDC
binds to the A receptors and induces the observed effect. At high concentrations, the A receptors are still activated and EDC binds to the B receptors,
which induces the opposite effect, resulting in an NMDR. Notes: A = Receptor A; B = Receptor B; xe = xenobiotic (e.g., EDC); affinity for A > B.
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ies suggested that desensitization, presumably through de-
creased expression of target receptors (estrogen receptors)
after administering a high dose of substance (i.e., DES or
E2), was responsible for the observed NMDR [25,44,52].
Time-dependent receptor desensitization is well estab-
lished for gonadotropin-releasing hormone (GnRH), which
is, at normal pulsatile low concentrations, required for fer-
tility. Higher concentrations of synthetic GnRH agonistsFigure 3 Mechanism of the NMDR phenomenon induced by “recepto
receptors and induces the observed effect. At high concentrations, numero
characterized by receptor desensitization. Consequently, the intensity of th
R = receptor; xe = xenobiotic (e.g., EDC).initially stimulate testosterone levels, but over time the
level of plasma testosterone drastically decreases, resulting
in infertility [69]. However, in the previously mentioned
studies, specific experiments to address the validity of a
mechanism involving time-dependent receptor desensitiza-
tion or down regulation were not performed.
NMDR relationships may also be caused by metabolic
modulation (Figure 4), as suggested in 2 studies [16,38].
Modulation of gene expression due to formation ofr desensitization”. At low concentrations, EDC binds to some
us receptors are bound, resulting in a down-regulation phenomenon
e effect is decreased, resulting in an NMDR. Note: (-) = negative effect;
Figure 4 Mechanism of the NMDR relationship phenomenon induced by one of the “metabolic effect” hypotheses. At low concentrations,
EDC is catabolized into active metabolites that induce the observed effect. At high concentrations, the metabolic system is saturated, and the parent
substance induces an opposite effect, resulting in an NMDR relationship. Note: Mtb =metabolite; xe = xenobiotic (e.g., EDC).
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proposed to explain an observed NMDR (Figure 5) [70].
Stepwise decision tree: case study on BPA
To consider all criteria in a systematic way, the stepwise
decision tree previously described in the Material andFigure 5 Mechanism of the NMDR relationship phenomenon induced
binds to the hormone receptor and forms mixed-ligand dimers that block
are more likely to form and induce a response. Note: H = endogenous hormMethods section (Figure 1) was applied to each selected
NMDR profile reported for 10 BPA in vivo studies
reporting NMDR curves. From these studies, 49 NMDR
relationships were identified. There were many effects
reported in these studies following exposure to BPA.
These effects included an alteration of the response ofby the “mixed-ligand” hypothesis. At low concentrations, the EDC
endogenous hormone activity. At high concentrations, dimers of EDCs
one; R = hormone receptor; xe = xenobiotic (e.g., EDC).
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mammary gland sensitivity to estrogens in mice [71] and
increase in mammary tumorigenesis and metastasis in
transgenic mice [45]. These effects also included alter-
ations of uterine morphology and expression of estrogen
and progesterone receptors in mice [40] and decreased
fertility and fecundity in mice [72]. Additional effects in-
cluded a deficit in the sexual behavior of male rats [46]
and alterations in liver expression of several genes in-
volved in lipogenesis [50]. The proposed decision tree
could have been used to analyze NMDR relationships
observed in in vitro studies. However, since in vitro
studies were usually not selected as key studies for
quantitative risk assessments, it was therefore decided
to focus this analysis on in vivo studies.
Step 1: study quality assessment
The Klimisch score was used as an ancillary approach to
evaluate the quality of the reported experimental data
[13]. Klimisch categories 1, 2 or 3 are also assigned by the
software-based tool “ToxRTool” (Toxicological data Reli-
ability Assessment Tool). This tool was developed within
the context of an ECVAM funded project to provide com-
prehensive criteria and guidance for evaluations of the in-
herent quality of in vivo and in vitro toxicological data
(based on study reports or peer-reviewed publications). As
a result, only the dose-responses of studies for which the
assigned criteria was Category 1 (reliable without restric-
tions) or Category 2 (reliable with restrictions) were con-
sidered further. None of the retrieved studies followed the
Organization for Economic Co-operation and Develop-
ment’s (OECD’s) guidelines and/or complied with Good
Laboratory Practices. However, because the protocols were
well described and results were reported with adequate
details, all the identified studies were considered to be
Category 2 (reliable with restrictions) and were accepted
for further analysis and scoring procedures.
A review of the protocol description indicated that
specific parameters related to the external contamination
of BPA to the laboratory animals were well controlled in
some studies. For example, in the studies of Ayyanan
et al. [39], Berger et al. [40], or Jones et al. [46], the mice
were bred in a BPA–free environment using polysulfone
or polypropylene cages and glass bottles. In the studies
of Cabaton et al. [72], the presence of substances that
may exhibit estrogenic activities in cages, food, water,
and bedding was tested and found to be negligible. In
the study of Jenkins et al. [45], the mice were fed
phytoestrogen-free food, housed in polypropylene cages,
and provided with water in glass bottles. In the study of
Marmugi et al. [50], the authors reported using a “stand-
ard diet,” and no information was provided about the
housing conditions, which was considered to be short-
comings [73].Step 2: number of tested doses (including control)
In the studies of Adewale et al. [36] and Vom Saal et al.
[64], the authors tested only 2 doses and a negative con-
trol group. Therefore, no further assessment of these 5
reported NMDR relationships from those studies was
possible. For all other in vivo studies, the number of
tested doses varied between 4 and 8, including the nega-
tive control group. All NMDR profiles from those stud-
ies were scored.
Step 3: availability of adequate data for specific statistical
assessment
In some studies, a posteriori tests performed by the au-
thors such as the Bonferroni multiple comparison test
[45,71] or analysis of variance (ANOVA) were used to
make comparisons between control and test groups or
to determine whether obvious NMDR relationships ex-
hibited a significant quadratic polynomial component
[39,40,46]. For some studies, sufficient data were not
available for specific statistical evaluation of the plausi-
bility of an NMDR profile. In those situations, the ana-
lysis criteria adapted from Calabrese and Baldwin was
used to provide enough confidence to grade the plausi-
bility of NMDR without a statistical test.
Step 4: criteria analysis procedure
On the basis of criteria derived from those of Calabrese
and Baldwin, 44 in vivo NMDR profiles were analyzed.
In one study [45], the available data did not allow us to
apply the analysis criteria for one endpoint (time to first
tumor latency) and thus the scoring procedure was not
performed. Finally, the criteria for 43 in vivo NMDR
were applied. Out of these 43 relationships, 23 had a no–
low or low-moderate plausibility of being non-monotonic,
and 20 had moderate or high and very high likelihood. On
the basis of the scoring criteria, the studies in which obvi-
ous NMDR could be considered for further analysis of
plausibility were those of Jenkins et al. [45], Jones et al.
[46], and Marmugi et al. [50].
Step 5: biological plausibility
The authors of the publications on the 20 dose-response
relationships scored with moderate to high and very high
plausibility of being non-monotonic proposed two
mechanistic explanations: a plurality of molecular targets
and/or negative feedback regulation. Jenkins et al. [45]
investigated the potential mechanisms behind the
NMDR profile. The data suggested that the NMDR pro-
file observed for tumorigenesis was due, at least partially,
to the differential ability of BPA to induce apoptosis at
each dose. Thus, at high doses of BPA, apoptosis would
counter-balance cell proliferation that contributed to
tumorigenesis at low doses. Jenkins et al. provided ex-
perimental data to support that hypothesis. Jones et al.
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of receptors, such as ERα, ERβ, androgen receptors or
thyroid hormone receptors with different affinities that
may explain the NMDR profile observed in male rat sex-
ual behavior. Jones et al. also mentioned the epigenetic
activity of BPA as a possible mode of action. However,
even if these mechanisms were considered relevant
modes of BPA action, no specific experimental data was
generated to support these hypotheses for these effects,
and then must be considered speculative. In the study of
Marmugi et al. [50], molecular mechanisms underlying
the observed responses were explored and non dose-
related expression of genes involved in lipid metabolism
could support their observations. Finally, only the stud-
ies of Jenkins et al. and Marmugi et al. could be consid-
ered for risk assessment. Whereas the study of Jones
et al. could be considered in a risk assessment process if
the hypothesis for mode of action is confirmed by fur-
ther testing.
Discussion
The purposes of this work were to review the literature
to identify NMDR relationships observed for some
EDCs, to develop a methodology to assess whether those
dose-response relationships were sufficiently reliable for
use in risk assessments. In this qualitative approach, a
judgment on the quality of the reviewed studies was not
introduced, except for the case study on BPA. Rather,
the aim was to derive tools that allow consideration of
NMDR relationships in risk assessments. In recent years,
NMDR profiles have been reported in the literature with
an increasing frequency from a variety of in vitro and
in vivo toxicological models involving substances that
affect hormonal systems [10,74,75]. In an extensive re-
view by Vandenberg et al. [10], they reported hundreds
of examples of possible NMDR relationships for more
than 20 natural hormones and more than 70 putative
EDCs. Those examples were from studies performed in
cultured cells, on whole animals or on human. It was
not a surprise that such relationships were observed be-
cause of the complexity resulting from the many modes
of action through which EDCs may influence the actions
of hormones. Along with the potential for complex
pharmaco/toxicodynamic influences (e.g., expression of
varying levels of multiple receptors and possible interac-
tions with native ligands), the critical feedback mecha-
nisms involved with regulation of hormonal systems
creates a level of increased complexity. Dose-response
relationship for EDCs would reflect this complexity and
would likely result in a non-monotonic dose-response.
Studies using several hormone-sensitive cell lines have
shown that NMDR relationships can result from a var-
iety of mechanisms [9,76]. However, that type of rela-
tionship is not exclusive to EDCs and is also observedfor chemicals substances that do not act on the endo-
crine system, and can be elicited by non-chemicals
stressors, such as ionizing radiations [7,77].
This work intentionally considers the in vivo and the
in vitro studies in which the authors of identified publi-
cations claimed that the dose-response relationships ob-
served during their experiments had an NMDR profile.
Here, the aim was not to compare monotonic dose-
response relationships with NMDR profiles, but to
evaluate the plausibility of non-monotonicity when
assessing the dose-response relationship from all avail-
able data. Indeed, NMDR profiles are still a controversial
issue, especially regarding their usefulness for risk as-
sessments [3,78].
In this current study, 51 experimental studies describing
170 NMDR profiles concerning EDCs and/or natural hor-
mones were selected. Out of these 51 investigations, the
two epidemiological studies [15,16] were excluded since
the scoring criteria procedure was not applied on them.
For the risk assessment point of view, the reproduci-
bility of the effects displaying NMDR profiles should be
taken into account because it supports the validity of an
observed relationship, and improves the confidence in
the biological observations reported. Considering repro-
ducibility of dose-response relationships, most of the
in vivo studies reporting NMDR profiles did not lead to
further experiments by other scientific teams which pre-
vent to assess their reproducibility. When studies appear
to have been replicated, there were often variations in
the experimental designs. This can be illustrated by the
in vitro studies of Kochukov et al. [28] and Wozniak
et al. [34] that both show U-shaped relationships for the
effects of BPA on prolactin release from rat pituitary cells.
However, due to differences in experimental systems,
differences in the shape of the resulting concentration-
response curves are observed that result in major differ-
ences in the apparent potency of BPA.
To some degree, the observation of a NMDR for a com-
pound at different endpoints can increase confidence in
the validity of NMDR relationship. In the Marmugi et al.
study [50], 18 NMDR profiles related to different meta-
bolic endpoints were reported: regulation of plasma insu-
lin (1 NMDR relationship) and changes in gene expression
related to lipid biosynthesis (17 NMDR relationships). In a
weight of evidence approach, these observations are con-
sidered with lower score compared to NMDR relation-
ships reported from 2 independent studies. It was not the
aim of the current study to collect and compare all of the
available measurements concerning one compound for
the same endpoints. The literature search, as part of the
current study, focused only on studies claiming NMDR re-
lationships, which did not afford the opportunity to re-
trieve studies that do not report NMDR relationships.
Therefore, it is currently unfeasible to establish with
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reproducible.
The scoring assessments used for this current study
have been adapted from those previously used by
Calabrese and Baldwin and Calabrese ans Blain [12,14]
for the quantitative identification of hormesis. We con-
sider these criteria to be a useful starting point to develop
a more general approach for analysis of NMDR relation-
ships. As a result of the current study, we have identified
some possible limitations of the approach in its current
form. For example, the zero equivalent point (ZEP) criteria
(Scores A and B) is an arbitrary definition applicable to
hormetic responses, which requires reversal of the response
and a complete return to the control value. However, this
value is not always observed or even expected for EDCs.
Future efforts should be made to elaborate more specific
criteria that are independent, but inclusive of hormesis,
that would result in a generalizable approach. Additionally,
it will be necessary to develop a scoring criterion that con-
siders dose range and the number of dose levels.
The specific nature (curve shape) of an NMDR relation-
ship observed from a toxicological assessment has import-
ant ramifications for the risk assessment. In different
cases, NMDR may be observed in concentration ranges
for which the effect is still adverse. Thus, U-shaped dose-
effect relationships could be observed with maximal ef-
fects at the extreme doses of the U-shape. In this case, it
may be expected that at a dose far lower than the lowest
tested dose levels, the effect will decrease again, because
infinite toxicity cannot be observed at dose levels close to
the zero dose. Conversely, bell-shaped dose-effect relation-
ships may be observed with minimal effects induced by
the two extreme doses that are not equal to the control re-
sponse. In this case, at very high doses, unspecific effects
will, for example, appear because the organism would be
completely overwhelmed by the substance. Thus, it ap-
pears credible that U-shaped and bell-shaped dose-
response relationships might correspond to two parts of a
same dose-response relationship. At high doses, the sub-
stances could impair biological processes by non-specific
mechanisms (e.g., choatropic effect, membrane disruption,
unspecific binding to proteins). However, because a
complete profile is rarely available, we are proposing two
ways to use NMDR in risk assessments. For bell-shaped
profiles, a NOAEL or a benchmark dose could be extrapo-
lated by modeling the ascending part of the dose-effect
relationship. For a U-shaped profile, it could be recom-
mended to experimentally verify, or to model, whether the
exposure levels are in the same range of doses for which
an NMDR relationship is observed. The main improve-
ment in the testing strategy would be to conduct a better
investigation of the dose-response relationship by testing
more doses, especially in the lower dose range, as it was
proposed during the workshop on “The low dose effectsand non-monotonic dose responses for endocrine active
chemicals: Science to practice”, held in Berlin, Germany,
on September 12–14th, 2012 [79]. These proposals could
be included in the revision of OECD’s guidelines. If more
dose groups are used, then the benchmark dose approach
might be preferred because of the possible reduction in
the number of animals per dose group. This approach was
also proposed at the European Food Safety Authority’s
17th Scientific Colloquium on Low Dose Response in
Toxicology and Risk Assessment, held in Parma, Italy, on
June 14 and 15, 2012 [2].
The relevant EDC modes of action that explain these
NMDR relationships are still poorly investigated. Of the
BPA studies fully considered, only 1 study explored the
hypothesized mechanisms of action [44]. In a recent re-
view from Vandenberg et al. [10], several mechanisms
producing NMDR relationships were discussed, but for
most of them only hypotheses were proposed which
could be considered purely speculative, and their bio-
logical basis could not be fully assessed. Mechanisms in-
volved in a non-monotonic profile are often described
in vitro, but defining the in vivo mode of action could be
much more complicated.
A significant biological plausibility of NMDR does not
systematically imply the causality of adverse effects. For
the purpose of risk assessments, the endpoints and the
potential impact on human health must be considered
when defining adversity. Determining whether an effect
is adverse can be difficult for subtle or small-magnitude
effects. In some situations, as previously mentioned, it
would be reasonable to think that some of the effects
characterized as presenting an NMDR might have a link-
age to compensatory effects and not to endocrine dis-
ruption, leading to an adverse effect [7]. However, some
of the endpoints identified in this study (Table 3) might
be considered to be adverse. Moreover, adversity should
also be considered regarding the exposure period. In-
deed, there are windows of sensitivity in which specific
subpopulations may be more vulnerable [80,81]. In ani-
mals, EDCs have the potential to cause reproductive or
developmental toxicity or several types of cancers in
hormonally responsive organs such as the uterus or the
mammary gland in females and the prostate in males
[82,83]. Thus, biological effects can be reversible or
weakly severe in adults, but can be serious and damaging
if exposures occur during specific critical life period (often
prenatal or perinatal). For some substances, the NMDR
profiles are observed exclusively when exposure occurs
during a sensitive period of development (i.e., fetuses)
when hormone-sensitive tissues such as uterine are most
susceptible to the effects of EDCs. Consequently, during
the fetal windows, low doses may impair physiological
mechanisms responsible for NMDR relationships that do
not exist during adulthood [9,76,81,82].
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For this current work, we developed a methodology to
consider individual NMDR relationships in a risk assess-
ment context. We expanded a stepwise decision tree to
assess the likelihood of NMDR relationships reported.
This analysis can be completed with a weight of evi-
dence approach to evaluate all the data available for the
substance of interest. This approach enables assessing
the consistency of the dose-response relationship. The
steps in this approach involve assembling the relevant
data (either positive or negative), evaluating these data
for quality and relevance, and integrating the different
points of evidence to support conclusions concerning
specific properties of the substance. Thus, the relevance
and the impact of NMDR relationships reported on
EDCs can be better understood and incorporated into
the risk assessment method to determine the potential
impacts of such substances on human health. Another
important point to determine is the extent of experi-
mental exposure (the range of exposure level in which
an NMDR relationship occurs). The literature review
performed for this current study enabled an analysis of
the NMDR relationship profiles reported by the authors.
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